1. Home
  2. AIZ vs RGEN Comparison

AIZ vs RGEN Comparison

Compare AIZ & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIZ
  • RGEN
  • Stock Information
  • Founded
  • AIZ 1892
  • RGEN 1981
  • Country
  • AIZ United States
  • RGEN United States
  • Employees
  • AIZ N/A
  • RGEN N/A
  • Industry
  • AIZ Property-Casualty Insurers
  • RGEN Medical/Dental Instruments
  • Sector
  • AIZ Finance
  • RGEN Health Care
  • Exchange
  • AIZ Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • AIZ 10.7B
  • RGEN 7.6B
  • IPO Year
  • AIZ N/A
  • RGEN N/A
  • Fundamental
  • Price
  • AIZ $204.92
  • RGEN $156.55
  • Analyst Decision
  • AIZ Buy
  • RGEN Buy
  • Analyst Count
  • AIZ 7
  • RGEN 12
  • Target Price
  • AIZ $225.57
  • RGEN $187.44
  • AVG Volume (30 Days)
  • AIZ 319.3K
  • RGEN 470.1K
  • Earning Date
  • AIZ 02-11-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • AIZ 1.44%
  • RGEN N/A
  • EPS Growth
  • AIZ 42.54
  • RGEN N/A
  • EPS
  • AIZ 14.00
  • RGEN N/A
  • Revenue
  • AIZ $11,755,800,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • AIZ N/A
  • RGEN $2.28
  • Revenue Next Year
  • AIZ $4.08
  • RGEN $9.88
  • P/E Ratio
  • AIZ $14.64
  • RGEN N/A
  • Revenue Growth
  • AIZ 8.84
  • RGEN N/A
  • 52 Week Low
  • AIZ $160.12
  • RGEN $113.50
  • 52 Week High
  • AIZ $230.55
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • AIZ 41.01
  • RGEN 60.07
  • Support Level
  • AIZ $197.28
  • RGEN $149.15
  • Resistance Level
  • AIZ $214.46
  • RGEN $160.64
  • Average True Range (ATR)
  • AIZ 3.77
  • RGEN 5.96
  • MACD
  • AIZ -1.28
  • RGEN 0.91
  • Stochastic Oscillator
  • AIZ 37.32
  • RGEN 79.57

About AIZ Assurant Inc.

Assurant Inc offers a range of property-casualty, health, employee benefit, and warranty insurance to a client base made up of individuals and institutions. Its segments are Global Housing, Global lifestyle, Corporate and Other. Global Housing provides lender-placed homeowners insurance, lender-placed manufactured housing insurance and lender-placed flood insurance; renters insurance and related products; and voluntary manufactured housing insurance, voluntary homeowners insurance and other specialty products. Global Lifestyle, the key revenue-generating segment, provides mobile device solutions and extended service products and related services for mobile devices, consumer electronics and appliances; vehicle protection; and credit protection and other insurance products.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: